Genetic Tests As Physician Fees Or Lab Fees? CMS Asks For Input
This article was originally published in The Pink Sheet Daily
Executive Summary
How much physician “work” is required for the application of genetic tests will determine how CMS begins reimbursing for more than 100 assays in 2013.
You may also be interested in...
With Genetic Test Codes Developed, CMS Undecided On How To Pay For Them
Specific reimbursement codes have been developed for the first time for more than 100 genetic tests, but they will not be adopted by Medicare until at least 2013 as CMS figures out how to incorporate them into the payment system.
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
Device Week, March 8, 2019 – Scott Gottlieb Resigns
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?